Story · Goldman Sachs
uniQure N.V. Q2 2026 Earnings Call Transcript
This is a transcript of uniQure N.V.'s second quarter 2026 earnings call held on July 29, 2026. The call was led by CEO Matthew Kapusta, CFO Christian Klemt, Chief Medical Officer Walid Abi-Saab, and Chief Customer & Strategy Officer Kylie O'Keefe. The company released its Q2 2026 financial results and filed its 10-Q with the SEC. The call includes prepared remarks from executives followed by a question-and-answer session with analysts from Guggenheim, Leerink Partners, Goldman Sachs, Mizuho, TD Cowen, Cantor Fitzgerald, Kempen, H.C. Wainwright, and Wolfe Research. The transcript covers the company's financial performance, strategic updates, and pipeline developments in gene therapy.
Editorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page itself is projected from evidence records.
- Current automated evidence projection